1002 related articles for article (PubMed ID: 21677094)
21. Passive cannabis smoke exposure and oral fluid testing.
Niedbala S; Kardos K; Salamone S; Fritch D; Bronsgeest M; Cone EJ
J Anal Toxicol; 2004 Oct; 28(7):546-52. PubMed ID: 15516313
[TBL] [Abstract][Full Text] [Related]
22. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
[TBL] [Abstract][Full Text] [Related]
23. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
Huestis MA; Sempio C; Newmeyer MN; Andersson M; Barnes AJ; Abulseoud OA; Blount BC; Schroeder J; Smith ML
J Anal Toxicol; 2020 Oct; 44(7):651-660. PubMed ID: 32369162
[TBL] [Abstract][Full Text] [Related]
24. In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis.
Scheidweiler KB; Schwope DM; Karschner EL; Desrosiers NA; Gorelick DA; Huestis MA
Clin Chem; 2013 Jul; 59(7):1108-17. PubMed ID: 23519966
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.
Swortwood MJ; Newmeyer MN; Andersson M; Abulseoud OA; Scheidweiler KB; Huestis MA
Drug Test Anal; 2017 Jun; 9(6):905-915. PubMed ID: 27647820
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoids in oral fluid following passive exposure to marijuana smoke.
Moore C; Coulter C; Uges D; Tuyay J; van der Linde S; van Leeuwen A; Garnier M; Orbita J
Forensic Sci Int; 2011 Oct; 212(1-3):227-30. PubMed ID: 21763088
[TBL] [Abstract][Full Text] [Related]
27. Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.
Scheidweiler KB; Newmeyer MN; Barnes AJ; Huestis MA
J Chromatogr A; 2016 Jul; 1453():34-42. PubMed ID: 27236483
[TBL] [Abstract][Full Text] [Related]
28. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis.
Desrosiers NA; Himes SK; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
Clin Chem; 2014 Apr; 60(4):631-43. PubMed ID: 24563491
[TBL] [Abstract][Full Text] [Related]
29. The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS.
Molnar A; Fu S; Lewis J; Allsop DJ; Copeland J
Forensic Sci Int; 2014 May; 238():113-9. PubMed ID: 24699310
[TBL] [Abstract][Full Text] [Related]
30. Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws.
Bergamaschi MM; Karschner EL; Goodwin RS; Scheidweiler KB; Hirvonen J; Queiroz RH; Huestis MA
Clin Chem; 2013 Mar; 59(3):519-26. PubMed ID: 23449702
[TBL] [Abstract][Full Text] [Related]
31. Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users.
Lee D; Bergamaschi MM; Milman G; Barnes AJ; Queiroz RH; Vandrey R; Huestis MA
J Anal Toxicol; 2015 Oct; 39(8):580-7. PubMed ID: 26378131
[TBL] [Abstract][Full Text] [Related]
32. Are cannabinoids detected in hair after washing with Cannabio shampoo?
Cirimele V; Kintz P; Jamey C; Ludes B
J Anal Toxicol; 1999 Sep; 23(5):349-51. PubMed ID: 10488922
[TBL] [Abstract][Full Text] [Related]
33. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
Fabritius M; Chtioui H; Battistella G; Annoni JM; Dao K; Favrat B; Fornari E; Lauer E; Maeder P; Giroud C
Anal Bioanal Chem; 2013 Dec; 405(30):9791-803. PubMed ID: 24202191
[TBL] [Abstract][Full Text] [Related]
34. Cannabinoid stability in authentic oral fluid after controlled cannabis smoking.
Lee D; Milman G; Schwope DM; Barnes AJ; Gorelick DA; Huestis MA
Clin Chem; 2012 Jul; 58(7):1101-9. PubMed ID: 22532594
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoid concentrations in hair from documented cannabis users.
Huestis MA; Gustafson RA; Moolchan ET; Barnes A; Bourland JA; Sweeney SA; Hayes EF; Carpenter PM; Smith ML
Forensic Sci Int; 2007 Jul; 169(2-3):129-36. PubMed ID: 16963215
[TBL] [Abstract][Full Text] [Related]
36. Validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method to detect cannabinoids in whole blood and breath.
Hubbard JA; Smith BE; Sobolesky PM; Kim S; Hoffman MA; Stone J; Huestis MA; Grelotti DJ; Grant I; Marcotte TD; Fitzgerald RL
Clin Chem Lab Med; 2020 Apr; 58(5):673-681. PubMed ID: 31527291
[TBL] [Abstract][Full Text] [Related]
37. Detection of Δ
Arkell TR; Kevin RC; Stuart J; Lintzeris N; Haber PS; Ramaekers JG; McGregor IS
Drug Test Anal; 2019 Oct; 11(10):1486-1497. PubMed ID: 31442003
[TBL] [Abstract][Full Text] [Related]
38. Validation of an enzyme immunoassay for detection and semiquantification of cannabinoids in oral fluid.
Schwope DM; Milman G; Huestis MA
Clin Chem; 2010 Jun; 56(6):1007-14. PubMed ID: 20360126
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous quantification of Δ(9)-tetrahydrocannabinol, 11-nor-9-carboxy-tetrahydrocannabinol, cannabidiol and cannabinol in oral fluid by microflow-liquid chromatography-high resolution mass spectrometry.
Concheiro M; Lee D; Lendoiro E; Huestis MA
J Chromatogr A; 2013 Jul; 1297():123-30. PubMed ID: 23726246
[TBL] [Abstract][Full Text] [Related]
40. Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration.
Milman G; Schwope DM; Schwilke EW; Darwin WD; Kelly DL; Goodwin RS; Gorelick DA; Huestis MA
Clin Chem; 2011 Nov; 57(11):1597-606. PubMed ID: 21875944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
